Synthetic virology: engineering viruses for gene delivery

被引:35
|
作者
Guenther, Caitlin M. [1 ]
Kuypers, Brianna E. [2 ]
Lam, Michael T. [1 ]
Robinson, Tawana M. [3 ]
Zhao, Julia [3 ]
Suh, Junghae [1 ,2 ]
机构
[1] Rice Univ, Dept Bioengn, Houston, TX 77005 USA
[2] Rice Univ, Syst Synthet & Phys Biol Program, Houston, TX USA
[3] Rice Univ, Dept Chem, Houston, TX USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
ADENOASSOCIATED VIRAL VECTORS; SITE-SPECIFIC MODIFICATION; IN-VITRO; DIRECTED EVOLUTION; AAV VECTOR; LENTIVIRAL VECTORS; MOLECULAR EVOLUTION; THERAPY VECTOR; CAPSID PROTEIN; ADENOVIRUS;
D O I
10.1002/wnan.1287
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The success of gene therapy relies heavily on the performance of vectors that can effectively deliver transgenes to desired cell populations. As viruses have evolved to deliver genetic material into cells, a prolific area of research has emerged over the last several decades to leverage the innate properties of viruses as well as to engineer new features into them. Specifically, the field of synthetic virology aims to capitalize on knowledge accrued from fundamental virology research in order to design functionally enhanced gene delivery vectors. The enhanced viral vectors, or bionic' viruses, feature engineered components, or parts', that are natural (intrinsic to viruses or from other organisms) and synthetic (such as man-made polymers or inorganic nanoparticles). Various design strategiesrational, combinatorial, and pseudo-rationalhave been pursued to create the hybrid viruses. The gene delivery vectors of the future will likely criss-cross the boundaries between natural and synthetic domains to harness the unique strengths afforded by the various functional parts that can be grafted onto virus capsids. Such research endeavors will further expand and enable enhanced control over the functional capacity of these nanoscale devices for biomedicine. WIREs Nanomed Nanobiotechnol 2014, 6:548-558. doi: 10.1002/wnan.1287 For further resources related to this article, please visit the . Conflict of interest: The authors declare no conflicts of interest.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 50 条
  • [1] Synthetic Virology: Building Viruses to Better Understand Them
    tenOever, Benjamin R.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (11): : 1 - 10
  • [2] Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices
    Chen, Maria Yanqing
    Butler, Susan S.
    Chen, Weitong
    Suh, Junghae
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2019, 11 (03)
  • [3] VIRUSES AND VIROLOGY
    MORRIS, WR
    SLADE, JS
    JOURNAL OF APPLIED BACTERIOLOGY, 1987, 63 (06): : R7 - R7
  • [4] Virology and immunology of gene therapy, or virology and immunology of high MOI infection with defective viruses
    P R Lowenstein
    Gene Therapy, 2003, 10 : 933 - 934
  • [5] Virology and immunology of gene therapy, or virology and immunology of high MOI infection with detective viruses
    Lowenstein, PR
    GENE THERAPY, 2003, 10 (11) : 933 - 934
  • [6] Synthetic polypeptides for drug and gene delivery, and tissue engineering Preface
    Yin, Lichen
    Cheng, Jianjun
    Deming, Timothy J.
    Vicent, Maria J.
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 178
  • [7] VIRUSES AND GENE ENGINEERING
    TIKHONENKO, TI
    VESTNIK AKADEMII MEDITSINSKIKH NAUK SSSR, 1983, (12): : 67 - 75
  • [8] Gene delivery - Without viruses
    Henry, CM
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (48) : 35 - 41
  • [9] Leveraging Synthetic Virology for the Rapid Engineering of Vesicular Stomatitis Virus (VSV)
    Moles, Chad M.
    Basu, Rupsa
    Weijmarshausen, Peter
    Ho, Brenda
    Farhat, Manal
    Flaat, Taylor
    Smith, Bruce F.
    VIRUSES-BASEL, 2024, 16 (10):
  • [10] THE VIROLOGY OF HUMAN IMMUNODEFICIENCY VIRUSES
    WEBER, JN
    WEISS, RA
    BRITISH MEDICAL BULLETIN, 1988, 44 (01) : 20 - 37